Business Context and Reporting Period
This Form 8-K is a current report filed by Phibro Animal Health Corporation (PAHC) on April 14, 2026, regarding an event that occurred on April 13, 2026. The Company is incorporated in Delaware and its Class A Common Stock trades on the NASDAQ Stock Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The material change reported is the resignation of a member of the Board of Directors:
- Resignation: Ms. Joyce J. Lee, a Class II Director, intends to resign effective April 15, 2026.
- Reason: The resignation is not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Investor Verification Checklist
- Verify the effective date of Ms. Lee's resignation (April 15, 2026).
- Confirm whether the Board has initiated a search for a replacement director.
- Review the composition of the Board to ensure quorum and committee assignments remain intact following the departure.